Mumbai, India-based Piramal Pharma Solutions is expanding its active pharmaceutical ingredient manufacturing capabilities in North America, the UK and Asia. The drugmaker will invest $55 million to build new plants and expand capabilities at existing sites, according to the company.
Sign up for BIO SmartBrief
Biotechnology industry news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.